Monoclonal antibodies to enable therapeutic tolerance to stem cell derived transplants?

Published: 23 October 2020
Commentary
Herman Waldmann
Herman Waldmann
Sir William Dunn School Of Pathology, University of Oxford, UK

Rejection of allogeneic stem cell derived transplants remains a major obstacle to their therapeutic potential. This brief article discusses how information obtained from induction of transplantation tolerance in mice, may provide clues to overcome this barrier.

Read now